Screening compound: RZYGDWUUGLAWKE-CQSZACIVSA-N

Screening compound: RZYGDWUUGLAWKE-CQSZACIVSA-N
Screening compound: RZYGDWUUGLAWKE-CQSZACIVSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
RZYGDWUUGLAWKE-CQSZACIVSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L397-0620

Molecular Formula

C21H21N5O4S2 (C21 H21 N5 O4 S2)

Compound Name

2-[1,5-dioxo-4-(tetrahydro-2-furanylmethyl)-4,5-dihydrothieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-2(1H)-yl]-N~1~-[3-(methylsulfanyl)phenyl]acetamide

IUPAC name

2-{712-dioxo-8-[(oxolan-2-yl)methyl]-5-thia-181011-tetraazatricyclo[7.3.0.0^{26}]dodeca-2(6)39-trien-11-yl}-N-[3-(methylsulfanyl)phenyl]acetamide

SMILES

CSc1cccc(NC(CN(C(N2c3c4scc3)=O)N=C2N(CC2OCCC2)C4=O)=O)c1

InChI

InChI=1S/C21H21N5O4S2/c1-31-15-6-2-4-13(10-15)22-17(27)12-25-21(29)26-16-7-9-32-18(16)19(28)24(20(26)23-25)11-14-5-3-8-30-14/h2,4,6-7,9-10,14H,3,5,8,11-12H2,1H3,(H,22,27)/t14-/m1/s1

InChI Key

RZYGDWUUGLAWKE-CQSZACIVSA-N

MDL Number (MFCD)

MFCD27251280

RZYGDWUUGLAWKE-CQSZACIVSA-N in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • Others
  • Proteases
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with RZYGDWUUGLAWKE-CQSZACIVSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound RZYGDWUUGLAWKE-CQSZACIVSA-N?
Check Price and Availability of RZYGDWUUGLAWKE-CQSZACIVSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of RZYGDWUUGLAWKE-CQSZACIVSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for RZYGDWUUGLAWKE-CQSZACIVSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for RZYGDWUUGLAWKE-CQSZACIVSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of RZYGDWUUGLAWKE-CQSZACIVSA-N available by request